Atlas Trials

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Clinical trial NCT06928662 · RECRUITING

Trial details

NCT number
NCT06928662
Sponsor
Fred Hutchinson Cancer Center
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent Acute Undifferentiated LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Mixed Phenotype Acute LeukemiaRecurrent Myelodysplastic SyndromeRefractory Acute Myeloid LeukemiaRefractory Acute Undifferentiated LeukemiaRefractory Chronic Myelomonocytic LeukemiaRefractory Mixed Phenotype Acute Leukemia
Start date
2025-09-23
Primary completion
2028-03-09
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.